Although the frequency of ASS deficiency does not equal the almost total absence of expression as reported in melanoma, it remains that 50% of the nearly 30 000 new cases of SCLC reported in the United States each year may be susceptible to arginine deprivation therapy. Here, ASS1 is linked to small cell lung carcinoma.